DAWN

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Day One Biopharmaceuticals Inc

NASDAQ | DAWN

9.14

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 5, 2025)

$748.78M

Market Cap

-

P/E Ratio

-0.89

EPS

$16.76

52 Week High

$5.63

52 Week Low

HEALTHCARE

Sector

DAWN Chart

Recent Chart
Price Action

DAWN Technicals

Tags:

DAWN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $126M
Total Revenue $131M
Cost Of Revenue $5.3M
Costof Goods And Services Sold $5.3M
Operating Income -$217M
Selling General And Administrative $32M
Research And Development $228M
Operating Expenses $343M
Investment Income Net -
Net Interest Income -
Interest Income $20M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2M
Income Before Tax -$88M
Income Tax Expense -$7.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$95M
Comprehensive Income Net Of Tax -
Ebit -$219M
Ebitda -$217M
Net Income -$95M

Revenue & Profitability

Earnings Performance

DAWN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $583M
Total Current Assets $562M
Cash And Cash Equivalents At Carrying Value $125M
Cash And Short Term Investments $125M
Inventory $3.3M
Current Net Receivables $14M
Total Non Current Assets $20M
Property Plant Equipment $4.7M
Accumulated Depreciation Amortization Ppe -
Intangible Assets $16M
Intangible Assets Excluding Goodwill $16M
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $407M
Other Current Assets $13M
Other Non Current Assets -
Total Liabilities $80M
Total Current Liabilities $73M
Current Accounts Payable $3.3M
Deferred Revenue -
Current Debt -
Short Term Debt $20K
Total Non Current Liabilities $6.6M
Capital Lease Obligations $2.6M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.6M
Other Current Liabilities $69M
Other Non Current Liabilities $761K
Total Shareholder Equity $503M
Treasury Stock -
Retained Earnings -$554M
Common Stock $10K
Common Stock Shares Outstanding $94M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$78M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $2M
Capital Expenditures $2.2M
Change In Receivables -
Change In Inventory -$3.2M
Profit Loss -
Cashflow From Investment -$231M
Cashflow From Financing $203M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $25M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$95M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $126M
Total Revenue $131M
Cost Of Revenue $5.3M
Costof Goods And Services Sold $5.3M
Operating Income -$217M
Selling General And Administrative $32M
Research And Development $228M
Operating Expenses $343M
Investment Income Net -
Net Interest Income -
Interest Income $20M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $2M
Income Before Tax -$88M
Income Tax Expense -$7.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$95M
Comprehensive Income Net Of Tax -
Ebit -$219M
Ebitda -$217M
Net Income -$95M

DAWN News

DAWN Profile

Day One Biopharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Day One Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California, dedicated to developing targeted therapies for genetically defined cancers. The company is distinguished by its robust pipeline of treatments designed to address significant unmet medical needs in oncology, employing precision medicine to enhance patient outcomes. By leveraging innovative scientific approaches that specifically target genetic mutations present in tumors, Day One positions itself as a pivotal player in the evolving landscape of cancer therapeutics. Its commitment to transforming the treatment paradigm underscores its potential for substantial impact in the biopharmaceutical sector.

CHR
-45.58%
$0.07
NVVE
-5.52%
$0.19
MTC
+409.86%
$1.55
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
SLDP
+51.55%
$8.51
YDKG
-5.55%
$0.05
ETHD
+20.91%
$5.26
F
+2.69%
$13.13
SMX
+38.80%
$2.04
PLTR
-1.48%
$187.90
T
-0.36%
$24.44
DNN
-2.18%
$2.68
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
PINS
-22.92%
$25.36
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
ONDS
+0.67%
$6.00
WTO
-0.20%
$0.04
CIFR
+9.77%
$24.71
SOFI
+2.38%
$30.07
RXRX
-0.80%
$4.96
SMCI
-11.11%
$42.13
TEVA
+20.16%
$24.58
INTC
+3.96%
$38.50
BAC
-2.04%
$52.44
AMZN
-1.84%
$249.32
KVUE
+1.94%
$16.28
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
IREN
+14.67%
$76.41
MARA
+3.06%
$17.13
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
U
+18.12%
$42.37
RGTI
+5.99%
$37.29
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
FUBO
+11.00%
$4.08
ADD
-25.47%
$0.05
WBD
+0.53%
$22.71
BURU
-2.17%
$0.28
NVO
+0.43%
$48.46
QS
+9.93%
$16.97
WULF
+2.46%
$15.38
BTBT
+3.14%
$3.28
EPWK
-7.75%
$0.06
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
RIOT
-1.58%
$18.97
ZDAI
+13.94%
$0.52
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
CMG
+0.72%
$31.97
APPS
+23.14%
$7.29
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
QBTS
+4.37%
$31.04
KDLY
-11.88%
$0.78
NGD
+2.48%
$6.80
GOOGL
+2.43%
$284.31
NIO
+2.30%
$7.32
BBD
+3.37%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
CGC
-5.83%
$1.12
HPE
+0.59%
$23.70
PCG
+1.05%
$16.32
AG
-7.82%
$10.65
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
ETWO
0.00%
$3.30
HBAN
+0.13%
$15.29
HOOD
-6.98%
$136.80
PBR
+2.57%
$12.13
ITUB
+1.55%
$7.49
MSPR
-27.89%
$0.47
AAPL
-0.18%
$269.53
CHR
-45.58%
$0.07
NVVE
-5.52%
$0.19
MTC
+409.86%
$1.55
ASST
+18.80%
$1.48
RIVN
+23.36%
$15.42
LNAI
+40.28%
$1.17
NVDA
-1.75%
$195.21
BYND
-4.31%
$1.33
VHAI
0.00%
$0.00
PFE
+1.37%
$24.63
RUBI
-49.75%
$0.30
SNAP
-2.00%
$7.32
PLUG
+4.76%
$2.64
TSLA
+4.00%
$462.07
GRAB
-2.50%
$5.64
SLDP
+51.55%
$8.51
YDKG
-5.55%
$0.05
ETHD
+20.91%
$5.26
F
+2.69%
$13.13
SMX
+38.80%
$2.04
PLTR
-1.48%
$187.90
T
-0.36%
$24.44
DNN
-2.18%
$2.68
AXDX
-61.36%
$0.03
AMD
+2.51%
$256.33
PINS
-22.92%
$25.36
ACHR
+0.26%
$9.58
GPUS
-7.02%
$0.34
AAL
+6.08%
$13.42
BITF
+5.72%
$4.05
CMBM
+58.82%
$3.24
ONDS
+0.67%
$6.00
WTO
-0.20%
$0.04
CIFR
+9.77%
$24.71
SOFI
+2.38%
$30.07
RXRX
-0.80%
$4.96
SMCI
-11.11%
$42.13
TEVA
+20.16%
$24.58
INTC
+3.96%
$38.50
BAC
-2.04%
$52.44
AMZN
-1.84%
$249.32
KVUE
+1.94%
$16.28
ADAP
-15.14%
$0.05
NFE
+13.99%
$1.53
AMCR
+3.04%
$8.11
BTG
+1.12%
$4.04
IREN
+14.67%
$76.41
MARA
+3.06%
$17.13
VALE
+3.09%
$12.31
DVLT
-7.83%
$1.64
CAN
+16.21%
$1.29
RIG
-0.12%
$3.89
U
+18.12%
$42.37
RGTI
+5.99%
$37.29
RMBL
+60.50%
$3.21
JOBY
-9.55%
$14.76
FUBO
+11.00%
$4.08
ADD
-25.47%
$0.05
WBD
+0.53%
$22.71
BURU
-2.17%
$0.28
NVO
+0.43%
$48.46
QS
+9.93%
$16.97
WULF
+2.46%
$15.38
BTBT
+3.14%
$3.28
EPWK
-7.75%
$0.06
SRM
+53.27%
$10.30
TLRY
+3.62%
$1.28
BMNR
+4.89%
$41.39
NCLH
-0.95%
$18.61
RIOT
-1.58%
$18.97
ZDAI
+13.94%
$0.52
HIMS
+3.11%
$44.12
NOK
+0.51%
$6.84
CMG
+0.72%
$31.97
APPS
+23.14%
$7.29
HTZ
-0.81%
$6.67
ALIT
-7.22%
$2.50
QBTS
+4.37%
$31.04
KDLY
-11.88%
$0.78
NGD
+2.48%
$6.80
GOOGL
+2.43%
$284.31
NIO
+2.30%
$7.32
BBD
+3.37%
$3.52
BW
+28.34%
$4.80
NVTS
-5.73%
$9.86
WLGS
-5.57%
$0.04
MU
+8.93%
$237.50
CGC
-5.83%
$1.12
HPE
+0.59%
$23.70
PCG
+1.05%
$16.32
AG
-7.82%
$10.65
PLTZ
+2.80%
$6.24
GGB
+5.11%
$3.59
ETWO
0.00%
$3.30
HBAN
+0.13%
$15.29
HOOD
-6.98%
$136.80
PBR
+2.57%
$12.13
ITUB
+1.55%
$7.49
MSPR
-27.89%
$0.47
AAPL
-0.18%
$269.53
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.